Barinthus Biotherapeutics shareholders approve all proposals at 2025 AGM

Barinthus Biotherapeutics plc.

Resolutions to re-elect directors Pierre A. Morgon and Joseph C. Scheeren passed with ~98.9% of votes cast.
PricewaterhouseCoopers LLP re-appointed as U.K. statutory auditors and ratified as independent auditor for FY2025.
Shareholders approved director remuneration policy and advisory compensation report for FY2024.
No dividend recommended for FY2024; statutory accounts received and noted.
Quorum achieved with 26,993,016 ordinary shares present or represented (66.9% of entitled shares).

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.